Regulus Therapeutics Inc.

Q2 2024 13F Holders

Symbol
RGLS
CUSIP
75915K309
Type
Equity
Class
COM
Num filings
70
Total reported value, excl. options
$98.1 M
Manager Report Date Value ($000) Shares Option Type